Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (2022_EKMK.13)
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 29 April 2025
Revised: 26 May 2025
Accepted: 27 May 2025
First Online: 10 June 2025
Declarations
:
: T.T. is founder and CSO/CMO of Cardior Pharmaceuticals Gmbh, a wholly-owned subsidiary of Novo Nordisk A/S Europe (outside of this MS).
